Kanagawa, Japan

Yasumasa Dekishima

This inventor holds 5 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Api Corporation, Mitsubishi Chemical Corporation. Active years: 2010-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yasumasa Dekishima. Retrieved from https://idiyas.com/inventor/yasumasa-dekishima

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.7

ph-index = 2

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2010-2024

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Inventor Yasumasa Dekishima: Pioneering Innovations in Pharmaceutical Chemistry

Introduction

Yasumasa Dekishima is a notable inventor based in Kanagawa, Japan, recognized for his contributions to pharmaceutical chemistry. With a total of five patents to his name, Dekishima has focused primarily on developing efficient methods for producing complex compounds used in modern medicine.

Latest Patents

Among his most significant inventions is a method for producing rosuvastatin calcium, a key medication used to lower cholesterol levels. His latest patent details a novel process that allows for the efficient and inexpensive production of rosuvastatin calcium and its intermediates at an industrial scale. This method ensures high purity and avoids the need for extremely low-temperature reactions or special asymmetric catalysts, making it a valuable innovation in the pharmaceutical field.

Career Highlights

Throughout his career, Yasumasa Dekishima has made impactful strides within prominent organizations. He has worked with Api Corporation and Mitsubishi Chemical Corporation, where he has utilized his expertise in chemical processes to contribute to the development of various pharmaceutical products.

Collaborations

Dekishima’s innovative journey has been supported by collaborations with esteemed colleagues, including Hiroshi Kawabata and Jun Takehara. These partnerships have fostered an environment of creativity and productivity, leading to advancements in the industry that benefit both companies and consumers.

Conclusion

Yasumasa Dekishima has established himself as a valuable inventor in the realm of pharmaceutical chemistry. His dedication to developing efficient production methods for critical medications showcases his commitment to innovation and improvement in healthcare solutions, positioning him as a key figure in the ongoing evolution of the pharmaceutical industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…